The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Thromboelastography in Hematology

Whole blood viscoelastic test for global coagulation assessment

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Thromboelastography in Hematology?

Thromboelastography uses a small whole blood sample placed in a heated cup with an oscillating pin to detect clot strength as fibrin and platelets create resistance, generating a tracing of reaction time, clot kinetics, alpha angle, maximum amplitude, and lysis at thirty minutes. ROTEM and TEG are two commercial systems with comparable principles but different parameter names and reagent activators.

Clinical applications include real time guidance of transfusion in trauma resuscitation, cardiopulmonary bypass weaning, liver transplantation, and postpartum hemorrhage by identifying specific defects in clotting factor activity, fibrinogen, platelet function, or hyperfibrinolysis within minutes. This allows targeted use of fresh frozen plasma, fibrinogen concentrate, platelets, or antifibrinolytic therapy rather than empiric massive transfusion protocols.

Limitations include lack of standardization across laboratories, sensitivity to sampling technique, inability to detect mild factor deficiencies or specific anticoagulant effects without additional reagents, and requirement for trained operators. Despite these constraints viscoelastic testing reduces blood product use, transfusion related lung injury, and mortality in selected high bleeding risk situations.

Symptoms

Active hemorrhage in trauma patient
Excessive bleeding after cardiac surgery
Coagulopathy during liver transplantation
Massive postpartum hemorrhage
Suspected hyperfibrinolysis in shock

Risk Factors

Severe trauma with shock
Cardiopulmonary bypass duration
Advanced liver disease
Massive obstetric bleeding
Coagulopathy of disseminated intravascular type

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When real time bleeding management is needed
  • When standard coagulation tests are too slow
  • When directed factor replacement is sought
  • When hyperfibrinolysis must be excluded
  • When platelet function assessment is required

Treatment Methods

01
Whole blood sample collection in citrated tube
02
Activator selection by clinical situation
03
Reaction time clot kinetics interpretation
04
Targeted product replacement based on tracing
05
Tranexamic acid for hyperfibrinolysis pattern
06
Fibrinogen concentrate for low maximum amplitude
07
Platelet transfusion for normal activity poor amplitude

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.